QIAGEN NV (QGEN)

33.67
NYSE : Health Technology
Prev Close 33.82
Day Low/High 33.52 / 33.89
52 Wk Low/High 32.33 / 41.55
Avg Volume 791.90K
Exchange NYSE
Shares Outstanding 226.97M
Market Cap 7.68B
EPS 0.80
P/E Ratio 41.62
Div & Yield N.A. (N.A)
QIAGEN Launches QCI Interpret Bioinformatics Features For Use For Blood Cancers As Well As A Novel Myeloid Gene Panel For GeneReader NGS System

QIAGEN Launches QCI Interpret Bioinformatics Features For Use For Blood Cancers As Well As A Novel Myeloid Gene Panel For GeneReader NGS System

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two novel products to deliver actionable insights on a wide range of blood cancers: a new workflow for the QIAGEN Clinical Insight (QCI) Interpret bioinformatics solution for...

NeuMoDx 288 (Photo: Business Wire)

NeuMoDx 288 (Photo: Business Wire)

QIAGEN N.V.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMGN, CIG.C, COTV, CTRE, GMS, HPT, IAG, NFEC, QGEN, SCVL, THR, TPHS, USFD, UVV Downgrades: BKE, IGT, TSLX, VRX Initiations: MGEN Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: B (Buy)